22 Grants
2021
Regulation of cutaneous immune function and anti-tumor immune responses by PPARgamma-mediated transrepressive signaling
Konger, Raymond L
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01BX003762-05), 2017-04-01 -- 2021-09-30
2020
Regulation of cutaneous immune function and anti-tumor immune responses by PPARgamma-mediated transrepressive signaling
Konger, Raymond L
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01BX003762-04), 2017-04-01 -- 2021-03-31
2019
Regulation of cutaneous immune function and anti-tumor immune responses by PPARgamma-mediated transrepressive signaling
Konger, Raymond L
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01BX003762-03), 04/01/2017 -- 03/31/2021
2018
Regulation of cutaneous immune function and anti-tumor immune responses by PPARgamma-mediated transrepressive signaling
Konger, Raymond L
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01BX003762-02), 04/01/2017 -- 03/31/2021
2017
Regulation of cutaneous immune function and anti-tumor immune responses by PPARgamma-mediated transrepressive signaling
Konger, Raymond L
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 1I01BX003762-01A1), 04/01/2017 -- 03/31/2021
2013
Characterization of persistent hyperemic foci and their role in photocarcinogenes
Konger, Raymond L
National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS) (ID: 5R21ES020965-02), $187,575USD, 08/13/2012 -- 07/31/2015
 
Platelet Activating Factor and Epidermal Cytotoxicity
Konger, Raymond L and TRAVERS, JEFFREY B
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL062996-14), $362,855USD, 07/01/1999 -- 03/31/2015
2012
Characterization of persistent hyperemic foci and their role in photocarcinogenes
Konger, Raymond L
National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS) (ID: 1R21ES020965-01A1), $244,720USD, 08/13/2012 -- 07/31/2014
 
Platelet Activating Factor and Epidermal Cytotoxicity
Konger, Raymond L and TRAVERS, JEFFREY B
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL062996-13), $381,150USD, 07/01/1999 -- 03/31/2014
2011
Platelet Activating Factor and Epidermal Cytotoxicity
Konger, Raymond L and TRAVERS, JEFFREY B
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL062996-12), $385,000USD, 07/01/1999 -- 03/31/2014
2010
Platelet Activating Factor and Epidermal Cytotoxicity
Konger, Raymond L and TRAVERS, JEFFREY B
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL062996-11), $385,000USD, 07/01/1999 -- 03/31/2014
 
Tumor Suppression Through Oxidized Glycerophosphocholines
Konger, Raymond L
National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS) (ID: 3R21ES017497-01S1), $11,430USD, 05/21/2010 -- 08/20/2010
 
Tumor Suppression Through Oxidized Glycerophosphocholines
Konger, Raymond L
National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS) (ID: 5R21ES017497-02), $192,500USD, 07/16/2009 -- 06/30/2011
2009
Platelet Activating Factor and Epidermal Cytotoxicity
Konger, Raymond L and TRAVERS, JEFFREY B
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2R01HL062996-10A2), $385,000USD, 07/01/1999 -- 03/31/2014
 
Tumor Suppression Through Oxidized Glycerophosphocholines
Konger, Raymond L
National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS) (ID: 1R21ES017497-01), $231,000USD, 07/16/2009 -- 06/30/2011
2005
The role of PPAR gamma in UVB-mediated proliferation, apoptosis, and differentiation
Konger, Raymond L
Indiana University Purdue University Indianapolis, $29,090.00, 2005 -- 2006
2004
ROLE OF PGE2 RECEPTORS EP2 AND EP3 ON SENESCENCE
Konger, Raymond L
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 5K08AR002150-05), $123,498USD, 08/01/2000 -- 07/31/2005
2003
ROLE OF PGE2 RECEPTORS EP2 AND EP3 ON SENESCENCE
Konger, Raymond L
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 5K08AR002150-04), $123,498USD, 08/01/2000 -- 07/31/2005
2002
ROLE OF PGE2 RECEPTORS EP2 AND EP3 ON SENESCENCE
Konger, Raymond L
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 7K08AR002150-03), $123,498USD, 08/01/2000 -- 07/31/2005
2001
ROLE OF PGE2 RECEPTORS EP2 AND EP3 ON SENESCENCE
Konger, Raymond L
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 5K08AR002150-02), $123,498USD, 08/01/2000 -- 06/30/2002
2000
ROLE OF PGE2 RECEPTORS EP2 AND EP3 ON SENESCENCE
Konger, Raymond L
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 1K08AR002150-01A1), $123,498USD, 08/01/2000 -- 07/31/2005
 
Role of PGE2 receptors, EP2 & EP3, in senescence
Konger, Raymond L
K08 Ar02150 05, $617,490.00, 2000 -- 2005